Ischaemia–reperfusion (I–R) injury, initiated via bursts of reactive oxygen species produced
during the reoxygenation phase following hypoxia, is well known in a variety of acute …

COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …

The risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well
characterized in multi-national settings with appropriate controls. We leveraged electronic …

Background Although a high prevalence of pulmonary embolism (PE) has been reported in
association with coronavirus disease 2019 (COVID-19) in critically ill patients, nationwide …

The COVID-19 pandemic has been a public health issue around the world in the last few
years. Currently, there is no specific antiviral treatment to fight the disease. Thus, it is …

The angiotensin-converting enzyme 2 (ACE2) is a type I integral membrane that exists in two
forms: the first is a transmembrane protein; the second is a soluble catalytic ectodomain of …

The SARS-CoV-2 virus has caused a pandemic, infecting nearly 80 million people
worldwide, with mortality exceeding six million. The average survival span is just 14 days …

Abstract The coronavirus 2019 (COVID‐19) infection pandemic has affected the care of
patients with heart failure (HF). Several consensus documents describe the appropriate …

(1) Background/Aim: People infected with SARS-CoV-2 may develop COVID-19 in a wide
range of clinical severity. Pulmonary fibrosis is characterized by several grades of chronic …

Venous thromboembolism, in particular, pulmonary embolism (PE), is a significant
contributor to the morbidity and mortality associated with COVID-19. In this study, we utilized …